Current perspectives into the evaluation and management of hepatitis B: a review

Area of Science:

• Hepatology
• Virology
• Internal Medicine

Background:

• Hepatitis B affects millions globally, with chronic hepatitis B (CHB) posing risks of cirrhosis and liver cancer.
• Understanding CHB pathophysiology is key for diagnosis and treatment decisions.
• Effective management of CHB is crucial to prevent severe complications and improve patient outcomes.

Purpose of the Study:

• To review the current landscape of chronic hepatitis B diagnosis and management.
• To highlight the efficacy of nucleos(t)ide analog inhibitors in viral suppression.
• To discuss the potential of novel therapies for a future cure.

Main Methods:

• Literature review of current hepatitis B research.
• Analysis of established treatment guidelines for CHB.
• Overview of emerging therapeutic strategies in hepatitis B treatment.

Main Results:

• Nucleos(t)ide analogs, entecavir and tenofovir, are effective in suppressing HBV replication.
• These treatments reduce the risk of long-term complications associated with CHB.
• Ongoing research is exploring innovative treatments with curative potential.

Conclusions:

• Current antiviral therapies significantly improve outcomes for patients with CHB.
• Further research into novel treatments is essential for achieving a potential cure for hepatitis B.
• Timely diagnosis and appropriate treatment selection are vital for managing CHB effectively.